About
Brii Biosciences Ltd (HK:2137) — investor relations, events, news, and company updates on 6ix.
Latest News
Dec 11 2025
Brii Biosciences and OpenBench Announce AI-Driven Collaboration for Proprietary Technology Platform
Nov 10 2025
Brii Biosciences Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025, Reinforcing BRII-179's Potential as a Curative Treatment for Chronic Hepatitis B
Nov 7 2025
Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine
Aug 21 2025
Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results
Jul 4 2025
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China
Financials
Revenue
HK$35.55 M
Market Cap
HK$1.02 B
EPS
-0.51
Google Übersetzer